Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer. It offers potent vaccines and immunotherapies that enable precise targeting and delivery of immunogens directly to the lymphatic system, substantially enhancing the body's own system of immune defenses.The company was founded in 2011 and is based in Cambridge, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 3, 2012 | Series Unknown | $3.30M | 1 |
![]() |
— | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 10, 2019
![]() |
Series B | $2.80M | Analytics | — |
Jan 1, 2019
![]() |
Seed | $7M | Bitcoin | — |
Aug 23, 2016
![]() |
Series A | $2M | Digital Entertainment | — |
Dec 2, 2013
![]() |
Series A | $2.30M | Digital Entertainment | — |
Jul 17, 2013
![]() |
Series A | — | E-Commerce | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series Unknown |